000 01494 a2200409 4500
005 20250513163649.0
264 0 _c19990329
008 199903s 0 0 eng d
022 _a1060-0280
024 7 _a10.1345/aph.18177
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYamreudeewong, W
245 0 0 _aEvaluation of amlodipine dosing for conversion of nifedipine extended-release to amlodipine in the treatment of hypertension.
_h[electronic resource]
260 _bThe Annals of pharmacotherapy
_cJan 1999
300 _a7-10 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAmlodipine
_xadministration & dosage
650 0 4 _aAntihypertensive Agents
_xadministration & dosage
650 0 4 _aCalcium Channel Blockers
_xadministration & dosage
650 0 4 _aDelayed-Action Preparations
650 0 4 _aDrug Costs
650 0 4 _aHumans
650 0 4 _aHypertension
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNifedipine
_xadministration & dosage
650 0 4 _aVasodilator Agents
_xadministration & dosage
700 1 _aHalverson, V J
700 1 _aLower, D L
700 1 _aKilpatrick, D M
700 1 _aEnlow, A M
700 1 _aMontopoli, G
773 0 _tThe Annals of pharmacotherapy
_gvol. 33
_gno. 1
_gp. 7-10
856 4 0 _uhttps://doi.org/10.1345/aph.18177
_zAvailable from publisher's website
999 _c9933935
_d9933935